Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

This study has been terminated.

( Enrollment suspended based upon interim analysis; subjects allowed to stay on study until disease progression. )

Study NCT00061646 Information provided by Abbott

First Received: June 2, 2003 Last Updated: August 10, 2007 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Carcinoma
Lung Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Carboplatin

More general drug interventions related to this trial

Sponsors listed in this trial

Abbott